EXOPHARM LTD(EX1.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

EX1.AU EXOPHARM LTD

Closed 05-02 16:12:00 AEST

0.03

+0.00

0.00%

High0.03	Low0.03	Vol0.00
Open0.03	D1 Closing0.03	Amplitude0.00%
Mkt Cap4.83M	Tradable Cap3.51M	Total Shares175.77M
T/O0.00	T/O Rate0.00%	Tradable Shares127.58M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"EX1.AU","market":"AU","secType":"STK","nameCN":"EXOPHARM LTD","latestPrice":0.0275,"timestamp":1714630320000,"preClose":0.0275,"halted":0,"volume":0,"delay":0,"nameEN":"EXOPHARM LTD","floatShares":127582268,"shares":175769226,"eps":-0.032252,"marketStatus":"Closed","change":0,"latestTime":"05-02 16:12:00 AEST","open":0.0275,"high":0.0275,"low":0.0275,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.032252,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1714694400000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.0275,"openAndCloseTimeList":[[1714608000000,1714629600000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"requestUrl":"/m/hq/s/EX1.AU","defaultTab":"news","newsList":[{"id":"2421581046","title":"Brokers meet Biotech – four Aussie companies driving medtech solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2421581046","media":"The Market Herald","top":-1,"share":"https://ttm.financial/m/news/2421581046?lang=en_us&edition=fundamental","pubTime":"2024-03-21 21:39","pubTimestamp":1711028340,"startTime":"0","endTime":"0","summary":"Biotech tends to follow a four to five year market cycle and those in the sector say there are signals that the next upturn has begun.That was the message today as four biotech companies and Life Sciences WA presented to 200 brokers and investors at the Broker Meets Biotech event in Perth.Blinklab is listing on the ASX early next month after raising $7 million with 20 cent shares. There have been eight studies since 2020, and a feasibility study including 280 child subjects, found the Software as a Medical Device had sensitivity for identifying autism spectrum disorder at 85 per cent. The company is working towards US Food and Drug Administration approval by early 2026.Other presenters today included Orthocell  chief operating officer Alex McHenry.Company investors include Chris Ellison of Mineral Resources  and the McCusker Family, and the company has Professor Fiona Wood and Kim Beazley on the Board.Meanwhile, HITIQ  has a smart mouthguard with 15,000 data points to measure the force","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://themarketonline.com.au/brokers-meet-biotech-four-aussie-companies-driving-medtech-solutions-2024-03-22/","is_publish_highlight":false,"gpt_icon":0},{"id":"2417872439","title":"BRIEF-Exopharm Says Signs Binding Agreement To Acquire Tryp Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2417872439","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2417872439?lang=en_us&edition=fundamental","pubTime":"2024-03-08 09:29","pubTimestamp":1709861373,"startTime":"0","endTime":"0","summary":"March 8  - Exopharm   :   * SIGNS BINDING AGREEMENT TO ACQUIRE TRYP THERAPEUTICS   * EXOPHARM INTENDS TO RAISE UP TO A$6.5 MILLION VIA A PUBLIC OFFER   * UNDERTAKEN INTERIM CAPITAL RAISE BY WAY OF CONVERTIBLE NOTE OF A$3.39 MILLION   * ACQUISITION WILL AMOUNT TO SIGNIFICANT CHANGE TO NATURE AND SCALE OF CO'S ACTIVITIES   * ISSUE PRICE OF A$0.02 PER SHARE FOR PUBLIC OFFER   * TO RAISE UP TO A$6.5 MILLION TO SUPPORT RESEARCH AND DEVELOPMENT OF TRYP'S LEAD PROGRAMSSource text for Eikon:    Further company coverage:    ","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2386500631","title":"BRIEF-Exopharm Says Ian Dixon's Employment As CEO Expected To End In Early 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2386500631","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2386500631?lang=en_us&edition=fundamental","pubTime":"2023-11-28 08:59","pubTimestamp":1701133199,"startTime":"0","endTime":"0","summary":"Nov 28  - Exopharm Ltd   :   * IAN DIXON EMPLOYMENT AS CEO IS EXPECTED TO END IN EARLY CY 24.   * IS MINIMISING NON- ESSENTIAL COSTS   * WORKING TO BRING POTENTIAL TRANSACTION TO SHAREHOLDERS AND HAVE COMPANY'S SHARES RECOMMENCE TRADING   * DETERMINED THAT A FULL-TIME CEO ROLE WILL NOT BE REQUIRED GOING FORWARD   * SEEKING A TRANSACTION THAT COULD RESULT IN A MATERIAL CHANGE IN COMPANY'S ACTIVITIESSource text for Eikon:    Further company coverage:    ","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.exopharm.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":1.5},{"period":"3month","weight":1.5},{"period":"6month","weight":1.5},{"period":"1year","weight":1.2917},{"period":"ytd","weight":1.5}],"compareEarnings":[{"period":"1week","weight":0.0127},{"period":"1month","weight":0.0196},{"period":"3month","weight":0.0689},{"period":"6month","weight":0.118},{"period":"1year","weight":0.1057},{"period":"ytd","weight":0.0928}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Exopharm Limited, a biopharmaceutical company, focuses on developing and commercializing human therapeutics in Australia. The company is Plexaris and Exomere products, including non-clinical, pre-clinical, and clinical testing for other medical conditions, such as dry age-related macular degeneration and osteoarthritis. Exopharm Limited was founded in 2013 and is headquartered in Melbourne, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.207955},{"month":2,"riseRate":0,"avgChangeRate":-0.121006},{"month":3,"riseRate":0.833333,"avgChangeRate":0.350455},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.079183},{"month":5,"riseRate":0.2,"avgChangeRate":-0.120391},{"month":6,"riseRate":0.6,"avgChangeRate":0.114493},{"month":7,"riseRate":0.6,"avgChangeRate":0.017476},{"month":8,"riseRate":0.4,"avgChangeRate":0.018898},{"month":9,"riseRate":0.6,"avgChangeRate":-0.013494},{"month":10,"riseRate":0,"avgChangeRate":-0.085062},{"month":11,"riseRate":0.4,"avgChangeRate":0.031371},{"month":12,"riseRate":0.666667,"avgChangeRate":0.025547}],"exchange":"ASX","name":"EXOPHARM LTD","nameEN":"EXOPHARM LTD"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"EXOPHARM LTD(EX1.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest EXOPHARM LTD(EX1.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"EXOPHARM LTD,EX1.AU,EXOPHARM LTD股票,EXOPHARM LTD股票老虎,EXOPHARM LTD股票老虎国际,EXOPHARM LTD行情,EXOPHARM LTD股票行情,EXOPHARM LTD股价,EXOPHARM LTD股市,EXOPHARM LTD股票价格,EXOPHARM LTD股票交易,EXOPHARM LTD股票购买,EXOPHARM LTD股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"EXOPHARM LTD(EX1.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest EXOPHARM LTD(EX1.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction